Viewing StudyNCT00520390



Ignite Creation Date: 2024-05-05 @ 6:39 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00520390
Status: COMPLETED
Last Update Posted: 2010-04-02
First Post: 2007-08-23

Brief Title: A Phase I Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma EZN-2208-02
Sponsor: Enzon Pharmaceuticals Inc
Organization: Enzon Pharmaceuticals Inc

Organization Data

Organization: Enzon Pharmaceuticals Inc
Class: INDUSTRY
Study ID: EZN-2208-02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Enzon Pharmaceuticals Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators